UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic significance of copy number variation in B-cell acute lymphoblastic leukemia

Frontiers in oncology, 2022-08, Vol.12, p.981036-981036

2022

Volltextzugriff (PDF)

Acute myeloid leukemia fusion genes can be found in CD33‐negative cells

International journal of laboratory hematology, 2022-12, Vol.44 (6), p.1111-1114

2022

Volltextzugriff (PDF)

Early‐salvage therapy with venetoclax‐based regimens for induction failure and poor early response acute lymphoblastic leukaemia: A retrospective case series of 13 patients

British journal of haematology, 2022-12, Vol.199 (5), p.772-776

2022

Volltextzugriff (PDF)

Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study

BMC infectious diseases, 2023-11, Vol.23 (1), p.796-796, Article 796

2023

Volltextzugriff (PDF)

Identification and lineage restriction analyses of preleukemia cells in a sporadic biallelic CEBPA mutated acute myeloid leukemia patient

International journal of laboratory hematology, 2021-06, Vol.43 (3), p.e145-e147

2021

Volltextzugriff (PDF)

Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3)

Diagnostic pathology, 2022-10, Vol.17 (1), p.1-74, Article 74

2022

Volltextzugriff (PDF)

Adjuvant ruxolitinib therapy relieves steroid-refractory cytokine-release syndrome without impairing chimeric antigen receptor-modified T-cell function

Immunotherapy, 2020-10, Vol.12 (14), p.1047-1052

2020

Volltextzugriff (PDF)

Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia

Haematologica (Roma), 2020-09, Vol.106 (5), p.1491-1495

2020

Volltextzugriff (PDF)

Treatment of STAT5b-RARA positive acute promyelocytic leukemia by Venetoclax combining with homoharringtonine, cytarabine: A case report and literature review

Blood science, 2022-04, Vol.4 (2), p.93-96

2022

Volltextzugriff (PDF)

A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia

Hematology (Luxembourg), 2022-12, Vol.27 (1), p.518-522

2022

Volltextzugriff (PDF)

Heterogeneity analysis of the CEBPAdm AML based on bZIP region mutations

Blood science, 2023-04, Vol.5 (2), p.101-105

2023

Volltextzugriff (PDF)

Effects of different aberrations in the CRLF2 gene on the biological characteristics and drug sensitivities of Nalm6 cells

International journal of laboratory hematology, 2021-06, Vol.43 (3), p.441-449

2021

Volltextzugriff (PDF)

Serum albumin is associated with the inherent property of acute myeloid leukemia and correlates with patient outcomes

Blood science, 2024-04, Vol.6 (2), p.e00189-e00189

2024

Volltextzugriff (PDF)

Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population

Journal of hematology and oncology, 2018-02, Vol.11 (1), p.18-18, Article 18

2018

Volltextzugriff (PDF)

Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic Leukemia

Frontiers in oncology, 2021-06, Vol.11, p.677034-677034

2021

Volltextzugriff (PDF)

Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial

Experimental hematology & oncology, 2023-05, Vol.12 (1), p.45-10, Article 45

2023

Volltextzugriff (PDF)

Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia

Blood science, 2023-01, Vol.5 (1), p.32-38

2023

Volltextzugriff (PDF)

Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells

Blood science, 2022-01, Vol.4 (1), p.38-43

2022

Volltextzugriff (PDF)

The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/ FUS::ERG

Blood science, 2024-04, Vol.6 (2), p.e00188-e00188

2024

Volltextzugriff (PDF)

The clinical characteristics and prognosis in adult Ph negative acute lymphoblastic leukemia with TP53 aberrations

Experimental hematology & oncology, 2022-04, Vol.11 (1), p.22-22, Article 22

2022

Volltextzugriff (PDF)

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified

Experimental hematology & oncology, 2021-09, Vol.10 (1), p.1-46, Article 46

2021

Volltextzugriff (PDF)

The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission

Clinical case reports, 2017-10, Vol.5 (10), p.1594-1596

2017

Volltextzugriff (PDF)

The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia

Blood science, 2022-01, Vol.4 (1), p.44-46

2022

Volltextzugriff (PDF)

Auer rods in mixed phenotype acute leukemia, T/myeloid: A report of three cases

Leukemia research reports, 2021-01, Vol.15, p.100236-100236, Article 100236

2021

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(109)
Berichte
(6)

Sprache

Englisch
(114)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prognostic significance of copy number variation in B-cell acute lymphoblastic leukemia

Acute myeloid leukemia fusion genes can be found in CD33‐negative cells

Early‐salvage therapy with venetoclax‐based regimens for induction failure and poor early response acute lymphoblastic leukaemia: A retrospective case series of 13 patients

Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study

Identification and lineage restriction analyses of preleukemia cells in a sporadic biallelic CEBPA mutated acute myeloid leukemia patient

Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3)

Adjuvant ruxolitinib therapy relieves steroid-refractory cytokine-release syndrome without impairing chimeric antigen receptor-modified T-cell function

Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia

Treatment of STAT5b-RARA positive acute promyelocytic leukemia by Venetoclax combining with homoharringtonine, cytarabine: A case report and literature review

A short report of novel RARG-HNRNPM fusion gene in resembling acute promyelocytic leukemia

Heterogeneity analysis of the CEBPAdm AML based on bZIP region mutations

Effects of different aberrations in the CRLF2 gene on the biological characteristics and drug sensitivities of Nalm6 cells

Serum albumin is associated with the inherent property of acute myeloid leukemia and correlates with patient outcomes

Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia

Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population

Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic Leukemia

Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial

Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia

Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells

The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/ FUS::ERG

The clinical characteristics and prognosis in adult Ph negative acute lymphoblastic leukemia with TP53 aberrations

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified

The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission

The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia

Auer rods in mixed phenotype acute leukemia, T/myeloid: A report of three cases

Aktive Filter

Suchergebnisse filtern